Publications
Specialty
Search
The Dermatologist
04/11/2024
Researchers aimed to enhance acne detection by assessing image quality, accurately segmenting lesions, and precisely grading acne types.
Journal of Clinical Pathways
04/11/2024
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
The Dermatologist
04/11/2024
Researchers aimed to assess the effectiveness of the IL-23 inhibitor risankizumab in patients with psoriatic arthritis.
The Dermatologist
04/11/2024
Researchers aimed to explore the common inflammatory mechanisms underlying the high comorbidity between psoriasis and obesity.
Oncology
04/11/2024
Thomas Powles, MBBS, MD, discusses results from the phase 3 EV-302 trial, which found enfortumab vedotin plus pembrolizumab improved survival outcomes among patients with previously untreated advanced urothelial carcinoma.
Annals of Long-Term Care
04/11/2024
A healthy eating plan called the Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) diet may help older adults slow biological aging and protect against dementia, according to a study published in the Annals of Neurology.
First Report Managed Care
04/11/2024
An educational initiative aiming to improve access to high-quality care for individuals with atopic dermatitis by expanding managed care professionals' understanding of this condition will be presented at AMCP 2024.
Annals of Long-Term Care
04/11/2024
Eisai recently submitted a supplemental Biologics License Application to the US Food and Drug Administration (FDA) for monthly intravenous (IV) maintenance dosing for lecanemab-irmb (Leqembi), Eisai and partner Biogen Inc. announced. Leqembi is indicated for the treatment of Alzheimer disease (AD) in patients with mild cognitive impairment or mild dementia.
First Report Managed Care
04/11/2024
New research to be presented at AMCP 2024 sheds light on the challenges faced by patients with chronic idiopathic constipation in accessing and affording medication, highlighting the need for improved awareness and insurance coverage.
Pharmacy Learning Network
04/11/2024
In a first-of-its-kind, historic decision, the Minnesota Court of Appeals has held that it is illegal sex discrimination under the Minnesota Human Rights Act for a pharmacist to refuse to fill a legitimate prescription for emergency contraception.
First Report Managed Care
04/11/2024
“These data show that the burden of care for NASH is substantial, and compared with those without progression, the annual costs per person with progression are at least 2-fold higher, with the gap increasing over time,” said researchers that will present at AMCP 2024.
First Report Managed Care
04/11/2024
Bacterial diversity is decreased in the eyelashes of patients with Demodex blepharitis compared with healthy volunteers, according to a study published online in Parasites & Vectors.
Integrated Healthcare Executive
04/11/2024
The cyberattack on Change Healthcare, which has disrupted insurance claims processes for medical institutions nationwide, is not expected to hurt the credit ratings of not-for-profit hospitals, Fitch Ratings recently announced. Change Healthcare is a billing and payment unit of UnitedHealth Group.
Cath Lab Digest, CardioVascular, Journal of Invasive Cardiology
04/11/2024
The Acolyte Image Guided Crossing and Re-Entry Catheter System is designed to facilitate the placement and positioning of guidewires and catheters within the coronary vasculature for the treatment of patients with coronary chronic total occlusions (CTOs) who continue to experience symptoms following medical therapy.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/11/2024
Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollment in the VISTA U.S. early feasibility study offering a new transcatheter tricuspid valve technology for severe tricuspid valve regurgitation. Paul Sorajja, MD, successfully completed this first procedure for a patient in the United States.
Lymphoma, Leukemia & Myeloma Network
04/11/2024
Noa Biran, MD, reviews data surrounding 5 immunotherapy options for patients with multiple myeloma at the 2024 Great Debates and Updates in Hematologic Malignancies meeting in New York, New York.
IO Learning
04/11/2024
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
EP Lab Digest
04/11/2024
Featured is the Session 17 Roundtable entitled "Meet the Presidents: How Presidents of Societies Influence the Management of AF" from WAFib 2024.
Advances in Inflammatory Bowel Disease Network
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.